HF
AMED

HRT Financial’s Amedisys AMED Stock Holding History

HRT Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,257
Closed -$1.8M – 2814
2025
Q2 		$1.8M Sell
18,257
-52,715
-74% -$4.99M 0.01% 973
2025
Q1 		$6.57M Buy
+70,972
New +$6.54M 0.04% 340
2024
Q4 		– Sell
-13,805
Closed -$1.33M – 2383
2024
Q3 		$1.33M Buy
13,805
+6,652
+93% +$649K 0.01% 1080
2024
Q2 		$656K Sell
7,153
-6,943
-49% -$644K ﹤0.01% 1178
2024
Q1 		$1.3M Buy
14,096
+6,249
+80% +$586K 0.01% 764
2023
Q4 		$745K Buy
+7,847
New +$733K 0.01% 1140
2023
Q2 		– Sell
-9,233
Closed -$679K – 2413
2023
Q1 		$679K Sell
9,233
-9,343
-50% -$808K 0.01% 1176
2022
Q4 		$1.55M Buy
+18,576
New +$1.67M 0.02% 715
2022
Q3 		– Sell
-35,210
Closed -$3.7M – 2742
2022
Q2 		$3.7M Buy
+35,210
New +$4.5M 0.04% 337
2022
Q1 		– Sell
-2,033
Closed -$329K – 3040
2021
Q4 		$329K Sell
2,033
-38,309
-95% -$6.16M ﹤0.01% 2209
2021
Q3 		$6.01M Buy
40,342
+24,401
+153% +$5.07M 0.04% 266
2021
Q2 		$3.9M Buy
15,941
+9,829
+161% +$2.58M 0.04% 376
2021
Q1 		$1.62M Buy
+6,112
New +$1.72M 0.02% 723
2020
Q4 		– Sell
-5,206
Closed -$1.23M – 1803
2020
Q3 		$1.23M Sell
5,206
-25,519
-83% -$5.8M 0.04% 414
2020
Q2 		$6.1M Buy
+30,725
New +$5.73M 0.18% 97

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's AMED Position: Q3 2025 in Review

HRT Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 18,257 shares — an estimated $1.8M sold.

HRT Financial first reported a position in AMED in Q2 2020 and held it in 15 quarters. The position peaked at $6.57M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • HRT Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 18,257 Amedisys shares in Q3 2025, an estimated $1.8M.
  • HRT Financial first reported a position in Amedisys in Q2 2020 and held it in 15 quarters.
  • HRT Financial's Amedisys position peaked at $6.57M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.